17383 Sunset Boulevard
Suite A250
Pacific Palisades, CA 90272
United States
424-744-8055
https://aadibio.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 89
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Neil P. Desai Ph.D. | Founder & Executive Chairman | 710.35k | N/A | 1965 |
Mr. David J. Lennon Ph.D. | President, CEO & Director | 277.75k | N/A | 1971 |
Mr. Scott M. Giacobello CPA | CFO, Treasurer, Investor Relations & Corporate Communications | 643.23k | N/A | 1970 |
Dr. Loretta M. Itri F.A.C.P., M.D. | Chief Medical Officer | 617.45k | N/A | 1950 |
Mr. Stephen M. Rodin J.D. | Senior VP of Legal & General Counsel | N/A | N/A | 1976 |
Mr. Raymond G. Steitz | Senior VP of Human Resources & Chief Human Resources Officer | N/A | N/A | 1959 |
Mr. Bryan Ball | Chief Quality Officer & Senior VP of Manufacturing Operations | N/A | N/A | 1970 |
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Aadi Bioscience, Inc.’s ISS governance QualityScore as of 1 May 2024 is 8. The pillar scores are Audit: 8; Board: 7; Shareholder rights: 8; Compensation: 9.